BIOS EQUITY PARTNERS, LP 13D and 13G filings for Lantern Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:20 pm Sale | 2026-05-15 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 571,305 4.480% | -263,447 (-31.56%) | Filing |
| 2026-04-16 3:48 pm Sale | 2026-04-16 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 834,752 7.400% | -125,274 (-13.05%) | Filing |
| 2026-02-23 4:37 pm Sale | 2026-02-20 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 960,026 8.580% | -115,926 (-10.77%) | Filing |
| 2025-06-13 7:43 pm Sale | 2025-06-12 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 1,075,952 9.980% | -187,850 (-14.86%) | Filing |
| 2024-03-01 4:10 pm Sale | 2024-02-28 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 1,263,802 11.800% | -202,889 (-13.83%) | Filing |
| 2023-12-01 06:02 am Sale | 2023-11-29 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 1,466,691 13.600% | -508,150 (-25.73%) | Filing |
| 2022-03-22 4:15 pm Purchase | 2022-03-17 | 13D | LANTERN PHARMA INC LTRN | BIOS EQUITY PARTNERS, LP | 1,974,841 18.100% | 5,855 (+0.30%) | Filing |